Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jan 28;12:1570. doi: 10.1038/s41598-022-05513-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Representative optical coherence tomography images of baseline and final inner retinal layer thickness in each group. Baseline inner retinal layer thickness of bevacizumab group (A) showed a tendency to decrease at final visit (B), whereas baseline thickness of PRP group (C) increased at final visit (D). Thicknesses according to the ETDRS circle in each image are thickness of retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), and inner plexiform layer (IPL), respectively. Red line: internal limiting membrane, green line: RNFL, puple line: GCL, blue line: IPL.